Targeting glycolysis: a fragment based approach towards bifunctional inhibitors of hLDH-5.
hLDH-5 has emerged as a promising target for anti-glycolytic cancer chemotherapy. Here we report a first generation of bifunctional inhibitors, which show promising activity against hLDH-5.